pta20210623035
Release according to article 40 para. 1 WpHG

Biofrontera AG: Release according to Article 40, Section 1 of the WpHG

Leverkusen, Germany (pta035/23.06.2021/19:30 UTC+2) - Release of Voting Rights Announcement

Voting Rights Announcement

1. Details of issuer

Name: Biofrontera AG
Legal Entity Identifier (LEI): 391200D6GFSVFGFQTL13
Street: Hemmelrather Weg 201
Postal code: 51377
City: Leverkusen, Germany

2. Reason for notification
Voluntary group notification due to threshold contact of a subsidiary

3. Details of person subject to the notification obligation
Natural person (first name, surname): Wilhelm K. T. Zours
Date of birth: 28.07.1961

4. Names of shareholders holding directly 3% or more voting rights, if different from 3.
DELPHI Unternehmensberatung Aktiengesellschaft
Deutsche Balaton Aktiengesellschaft
SPARTA AG
Deutsche Balaton Biotech AG

5. Date on which threshold was crossed or reached
17.06.2021

6. Total positions

  % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG
New 29.96 3.09 33.04 56,717,385
Previous notification (if applicable) 0.00 0.00 0.00

7. Details on total positions

a. Voting rights attached to shares (Sec.s 33, 34 WpHG)

ISIN Absolute direct (Sec. 33 WpHG) Absolute indirect (Sec. 34 WpHG) In % direct (Sec. 33 WpHG) In % indirect (Sec. 34 WpHG)
DE0006046113 0 16,990,199 0.00 29.96
Total:   16   29.96

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
0 0.00
    Total: 0 0.00

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
28.12.2022 31.03.2021 to 16.12.2022 Both 1,750,000 3.09
      Total: 1,750,000 3.09

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- Strawtec Group AG
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 27.02 30.10
- ABC Beteiligungen AG 27.02 27.02
- Heidelberger Beteiligungsholding AG 27.02 27.02
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 27.02 30.10
- SPARTA AG 27.02 27.02
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 27.02 30.10
- Deutsche Balaton Biotech AG 29.95 29.95
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 27.02 30.10
- Altech Advanced Materials AG
-
- Wilhelm K. T. Zours
- DELPHI Unternehmensberatung Aktiengesellschaft 27.02 27.02
- VV Beteiligungen Aktiengesellschaft
- Deutsche Balaton Aktiengesellschaft 27.02 30.10
- Ming Le Sports AG

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting: N/A

Holding total positions (6.) after general meeting:

Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other useful information

DELPHI Unternehmensberatung Aktiengesellschaft, Deutsche Balaton Aktiengesellschaft, SPARTA AG, Deutsche Balaton Biotech AG, ABC Beteiligungen AG and Heidelberger Beteiligungsholding AG are parties to a voting agreement dated January 28, 2020.

Date
18.06.2021

(end)

Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Germany
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
E-Mail: ir@biofrontera.com
Website: www.biofrontera.com
ISIN(s): DE0006046113 (Share)
Stock Exchange(s): Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate
Other Stock Exchanges: Nasdaq
|